The Annual Report for the financial year 2024-25 has been attached herewith.
Reg. 34 (1) Annual Report.
Filed with BSE ·
6ix hasn’t read this filing yet.
View original source (BSE India)Dharti Proteins Ltd on 6ix
Earlier from Dharti Proteins
- Outcome Of 3Rd Monitoring Committee Meeting Of Dharti Proteins Limited (Formerly Known As Devika Proteins Limited) Held On 27Th April, 2026
- Format of the Initial Disclosure to be made by an entity identified as a Large Corporate: Annexure A
- Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
- Closure of Trading Window
- Announcement under Regulation 30 (LODR)-Newspaper Publication
Later from Dharti Proteins
- Compliances-Reg.24(A)-Annual Secretarial Compliance
- Board Meeting Intimation for Meeting Of Board Of Directors To Be Held On Friday, May 29, 2025.
- Intimation Of Listing Approval Received From BSE Limited For 5,00,000 Equity Shares Of Rs. 10/- Each.
- Intimation Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 For Change In ISIN Pursuant To Approved Resolution Plan Under CIRP
- Board Meeting Intimation for Meeting Of Board Of Directors To Be Held On Wednesday, July 15, 2026.
Follow Dharti Proteins into a list and get an email when it puts out news.
Follow Dharti Proteins